Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
Cash Flows From Operating Activities | |||||
Net Income | -46,011 | -38,048 | -32,354 | -25,966 | -20,166 |
Depreciation Amortization | 109 | 44 | 3 | 6 | 10 |
Accounts receivable | -871 | -557 | 0 | 0 | N/A |
Accounts payable and accrued liabilities | -1,423 | 193 | 2,794 | -453 | -34 |
Other Working Capital | -762 | -5,006 | 1,516 | 1,559 | 373 |
Other Operating Activity | 11,900 | 7,354 | 641 | 2,569 | 1,849 |
Operating Cash Flow | $-37,058 | $-36,020 | $-27,400 | $-22,285 | $-17,968 |
Cash Flows From Investing Activities | |||||
Change In Deposits | N/A | N/A | N/A | N/A | 3,594 |
PPE Investments | -127 | -151 | -25 | N/A | N/A |
Investing Cash Flow | $-127 | $-151 | $-25 | $0 | $3,594 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | 29,860 | N/A | N/A | N/A |
Debt Repayment | -1,025 | 0 | N/A | -6 | -10 |
Common Stock Issued | 55 | 59,708 | 42,482 | 23,002 | 23,535 |
Financing Cash Flow | $-970 | $89,568 | $42,482 | $22,996 | $23,525 |
Beginning Cash Position | 93,032 | 39,635 | 24,578 | 23,867 | 14,716 |
End Cash Position | 54,877 | 93,032 | 39,635 | 24,578 | 23,867 |
Net Cash Flow | $-38,155 | $53,397 | $15,057 | $711 | $9,151 |
Free Cash Flow | |||||
Operating Cash Flow | -37,058 | -36,020 | -27,400 | -22,285 | -17,968 |
Capital Expenditure | -127 | -151 | -25 | 0 | N/A |
Free Cash Flow | -37,185 | -36,171 | -27,425 | -22,285 | -17,968 |